Monosymptomatic enuresis: the therapeutic weapons.
J Biol Regul Homeost Agents
; 33(5 Suppl. 1): 45-51. Special Issue: Focus on Pediatric Nephrology, 2019.
Article
en En
| MEDLINE
| ID: mdl-31630713
ABSTRACT
Nocturnal enuresis (NE) was defined by the World Health Organization (ICD-10) and the American Psychiatric Association (DSM-5) as bed-wetting in children aged >5 years. In cases of mental retardation, the developmental age may be equivalent to 5 years. In this review, we focus on the current knowledge about the etiology of enuresis and the most recent therapeutical options. Both non-pharmacological and pharmacological therapies are included, although the relative effectiveness of each remains uncertain. To date, motivational, alarm and drug therapies are the mainstay of treatment. Alarm therapy remains the first-line treatment modality for NE, while desmopressin is the most commonly used medical treatment.
Palabras clave
Buscar en Google
Base de datos:
MEDLINE
Asunto principal:
Desamino Arginina Vasopresina
/
Enuresis Nocturna
Idioma:
En
Revista:
J Biol Regul Homeost Agents
Asunto de la revista:
BIOLOGIA
/
BIOQUIMICA
Año:
2019
Tipo del documento:
Article